Quest Diagnostics Incorporated
DGX
Peringkat dalam Saham
#933
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Harga Saham
$234.71
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$25.91B
Perubahan (1 hari)
-1.76%
Perubahan (1 tahun)
23.85%
Negara
US
Perdagangan Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Margin Operasi untuk Quest Diagnostics Incorporated (DGX)
Margin Operasi per October 2026 TTM: 14.14%
Menurut laporan keuangan dan harga saham terbaru dari Quest Diagnostics Incorporated, margin operasi saat ini (TTM) adalah 14.14%. Pada akhir 2024, margin operasi perusahaan adalah 13.63%.
Riwayat margin operasi untuk Quest Diagnostics Incorporated dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 14.14% | -2.68% |
| 2025 | 14.53% | 6.60% |
| 2024 | 13.63% | -0.07% |
| 2023 | 13.64% | -5.61% |
| 2022 | 14.45% | -34.53% |
| 2021 | 22.07% | 5.65% |
| 2020 | 20.89% | 31.14% |
| 2019 | 15.93% | 8.96% |
| 2018 | 14.62% | -3.24% |
| 2017 | 15.11% | -11.07% |
| 2016 | 16.99% | -9.00% |
| 2015 | 18.67% | 41.23% |
| 2014 | 13.22% | -35.95% |
| 2013 | 20.64% | 26.86% |
| 2012 | 16.27% | 22.79% |
| 2011 | 13.25% | -24.63% |
| 2010 | 17.58% | -3.57% |
| 2009 | 18.23% | 8.13% |
| 2008 | 16.86% | 3.56% |
| 2007 | 16.28% | -9.51% |
| 2006 | 17.99% | 2.27% |
| 2005 | 17.59% | 0.06% |
| 2004 | 17.58% | 4.71% |
| 2003 | 16.79% | 16.44% |
| 2002 | 14.42% | 27.16% |
| 2001 | 11.34% | 22.07% |
| 2000 | 9.29% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 17.97% | -98.73% |
US
|
|
| 20.42% | -98.56% |
US
|
|
| -10.70% | -100.76% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.43% |
US
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.